We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Glanbia Plc | LSE:GLB | London | Ordinary Share | IE0000669501 | ORD EUR0.06 (CDI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.79 | 4.69% | 17.65 | 16.86 | 18.44 | 6,640 | 16:35:13 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 5.43B | 344.5M | 1.2652 | 13.33 | 4.59B |
10 May 2024
Glanbia plc (the "Company"), the better nutrition company, reports that Tirlán Co-operative Society Limited has nominated Gerard O'Brien and Thomas Phelan to replace Patrick Murphy and Brendan Hayes respectively on the Board of the Company with effect from 1 June 2024. Patrick Murphy retired on 1 May 2024 and Brendan Hayes will retire on 31 May 2024.
This announcement is made in accordance with Rule 6.1.64 of Euronext Dublin Listing Rules and Rule 9.6.11 of the London Stock Exchange Listing Rules. The Company confirms that there are no other matters requiring disclosure under Rule 6.1.66 of Euronext Dublin Listing Rules and Rule 9.6.13 of the London Stock Exchange Listing Rules.
ENDS
For further information contact
Glanbia plc: +353 (0)56 777 2200
Liam Hennigan, Group Secretary & Head of Investor Relations: +353 (0)86 046 8375
Martha Kavanagh, Director of Corporate Affairs: +353 (0)87 646 2006
1 Year Glanbia Chart |
1 Month Glanbia Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions